Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learning.

human medicine neuroscience

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 12 01 2023
accepted: 26 04 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 30 4 2024
Statut: aheadofprint

Résumé

Gait is impaired in musculoskeletal conditions, such as knee arthropathy. Gait analysis is used in clinical practice to inform diagnosis and to monitor disease progression or intervention response. However, clinical gait analysis relies on subjective visual observation of walking, as objective gait analysis has not been possible within clinical settings due to the expensive equipment, large-scale facilities, and highly trained staff required. Relatively low-cost wearable digital insoles may offer a solution to these challenges. In this work, we demonstrate how a digital insole measuring osteoarthritis-specific gait signatures yields similar results to the clinical gait-lab standard. To achieve this, we constructed a machine learning model, trained on force plate data collected in participants with knee arthropathy and controls. This model was highly predictive of force plate data from a validation set (area under the receiver operating characteristics curve [auROC] = 0.86; area under the precision-recall curve [auPR] = 0.90) and of a separate, independent digital insole dataset containing control and knee osteoarthritis subjects (auROC = 0.83; auPR = 0.86). After showing that digital insole derived gait characteristics are comparable to traditional gait measurements, we next showed that a single stride of raw sensor time series data could be accurately assigned to each subject, highlighting that individuals using digital insoles can be identified by their gait characteristics. This work provides a framework for a promising alternative to traditional clinical gait analysis methods, adds to the growing body of knowledge regarding wearable technology analytical pipelines, and supports clinical development of at-home gait assessments, with the potential to improve the ease, frequency, and depth of patient monitoring.

Identifiants

pubmed: 38686919
doi: 10.7554/eLife.86132
pii: 86132
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Regeneron Pharmaceuticals
ID : N/A

Informations de copyright

© 2024, Wipperman et al.

Déclaration de conflit d'intérêts

MW Matthew F Wipperman, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. AL Allen Z Lin, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. KG Kaitlyn M Gayvert, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. BL Benjamin Lahner, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. SS Selin Somersan-Karakaya, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. XW Xuefang Wu, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. JI Joseph Im, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. ML Minji Lee, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. BK Bharatkumar Koyani, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. IS Ian Setliff, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. MT Malika Thakur, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. DD Daoyu Duan, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. AB Aurora Breazna, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. FW Fang Wang, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. WL Wei Keat Lim, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. GH Gabor Halasz, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. JU Jacek Urbanek, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. YP Yamini Patel, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. GA Gurinder S Atwal, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. JH Jennifer D Hamilton, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. SS Samuel Stuart, Employee and stockholder of Regeneron Pharmaceuticals, Inc.. OL Oren Levy, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. AA Andreja Avbersek, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. RA Rinol Alaj, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. SH Sara C Hamon, Employee and shareholder of Regeneron Pharmaceuticals, Inc.. OH Olivier Harari, Employee and shareholder of Regeneron Pharmaceuticals, Inc..

Auteurs

Matthew F Wipperman (MF)

Precision Medicine, Regeneron, Tarrytown, United States.

Allen Z Lin (AZ)

Molecular Profiling and Data Science, Regeneron, Tarrytown, United States.

Kaitlyn M Gayvert (KM)

Molecular Profiling and Data Science, Regeneron, Tarrytown, United States.

Benjamin Lahner (B)

Precision Medicine, Regeneron, Tarrytown, United States.

Selin Somersan-Karakaya (S)

Early Clinical Development and Experimental Sciences, Regeneron, Tarrytown, United States.

Xuefang Wu (X)

Clinical Outcomes Assessment and Patient Innovation, Regeneron, Tarrytown, United States.

Joseph Im (J)

Clinical Outcomes Assessment and Patient Innovation, Regeneron, Tarrytown, United States.

Minji Lee (M)

Molecular Profiling and Data Science, Regeneron, Tarrytown, United States.

Bharatkumar Koyani (B)

Clinical Outcomes Assessment and Patient Innovation, Regeneron, Tarrytown, United States.

Ian Setliff (I)

Molecular Profiling and Data Science, Regeneron, Tarrytown, United States.

Malika Thakur (M)

Clinical Outcomes Assessment and Patient Innovation, Regeneron, Tarrytown, United States.

Daoyu Duan (D)

Precision Medicine, Regeneron, Tarrytown, United States.

Aurora Breazna (A)

Biostatistics and Data Management, Regeneron, Tarrytown, United States.

Fang Wang (F)

Precision Medicine, Regeneron, Tarrytown, United States.

Wei Keat Lim (WK)

Molecular Profiling and Data Science, Regeneron, Tarrytown, United States.

Gabor Halasz (G)

Molecular Profiling and Data Science, Regeneron, Tarrytown, United States.

Jacek Urbanek (J)

Biostatistics and Data Management, Regeneron, Tarrytown, United States.

Yamini Patel (Y)

General Medicine, Regeneron, Tarrytown, United States.

Gurinder S Atwal (GS)

Molecular Profiling and Data Science, Regeneron, Tarrytown, United States.

Jennifer D Hamilton (JD)

Precision Medicine, Regeneron, Tarrytown, United States.

Samuel Stuart (S)

Precision Medicine, Regeneron, Tarrytown, United States.

Oren Levy (O)

Early Clinical Development and Experimental Sciences, Regeneron, Tarrytown, United States.

Andreja Avbersek (A)

Early Clinical Development and Experimental Sciences, Regeneron, Tarrytown, United States.

Rinol Alaj (R)

Clinical Outcomes Assessment and Patient Innovation, Regeneron, Tarrytown, United States.

Sara C Hamon (SC)

Precision Medicine, Regeneron, Tarrytown, United States.

Olivier Harari (O)

Early Clinical Development and Experimental Sciences, Regeneron, Tarrytown, United States.

Classifications MeSH